The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...
Most phenotypic variation in natural populations is attributable to multiple interacting loci, with allelic effects that are sensitive to the exact environmental conditions each individual experiences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results